Feb 19, 2020 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jan 23, 2020 - As of late, it has definitely been a great time to be an investor Momenta Pharmaceuticals
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Oct 31, 2019 - MNTA earnings call for the period ending September 30, 2019.
Oct 31, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q3 2019 Earnings Conference Call October 31, 2019, 08:30 AM ET Company Participants Patty Eisenhaur - VP of IR and Corporate Communications Craig Wheeler -
Oct 31, 2019 - Momenta (MNTA) delivered earnings and revenue surprises of -14.29% and 39.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Oct 24, 2019 - Momenta (MNTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
May 05, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q1 2019 Earnings Conference Call May 02, 2019, 08:30 ET Company Participants Patricia Eisenhaur - VP, IR & Communications Craig Wheeler - President, CEO
May 02, 2019 - MNTA earnings call for the period ending March 31, 2019.
Apr 25, 2019 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.